Updated:
InnerScope Hearing Technologies Inc.
InnerScope Hearing Technologies sells OTC hearing aids direct-to-consumer from Roseville, CA.
InnerScope Hearing Technologies Inc.
InnerScope Hearing Technologies Inc. is a hearing aid company headquartered in Roseville, California, that sells over-the-counter (OTC) devices directly to consumers. The firm raised public visibility after the FDA established a regulatory category for OTC hearing aids in October 2022, allowing products like its to bypass traditional prescription channels. The company's strategy centers on e-commerce distribution via its website, otchearingaid.store, offering devices at lower price points than prescription alternatives. It competes in the consumer health technology segment against larger players like Bose, Sony, and Eargo. InnerScope has not disclosed specific product sales figures or manufacturing partnerships, but its positioning suggests a focus on the mild-to-moderate hearing loss demographic that the OTC category targets. InnerScope has disclosed no team size, funding rounds, or institutional investors in public filings. The firm maintains a minimal public profile with limited financial disclosures. No additional offices, philanthropic vehicles, or linked entities were identified. InnerScope operates as a standalone public company in a regulatory-advantaged niche. Its structural differentiator is the OTC hearing aid model itself — a direct challenge to the audiology-protected distribution model that dominated the industry prior to 2022. The firm's ability to scale depends on consumer adoption of self-fit hearing solutions and regulatory enforcement against non-compliant devices.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Roseville
Corporate office
Roseville, CA, United States
Sector focus
Frequently asked questions
What is InnerScope Hearing Technologies' business model?
InnerScope sells over-the-counter hearing aids online through its website, otchearingaid.store. The direct-to-consumer model avoids audiologist fees and traditional retail markups, targeting adults with mild-to-moderate hearing loss. The company does not operate brick-and-mortar stores or clinic partnerships.
When did InnerScope begin operations?
InnerScope emerged after the FDA created a regulatory category for over-the-counter hearing aids in October 2022. The company's public filings indicate it operates in the post-regulatory market, selling devices without requiring a prescription. An exact founding date has not been publicly disclosed.
Who are InnerScope's main competitors?
InnerScope competes with other OTC hearing aid brands including Bose (Bose SoundControl), Sony (Sony CRE-C10), Eargo, and Jabra Enhance. These companies also sell directly to consumers online. The broader hearing aid market remains dominated by prescription-focused firms like Sonova and Demant, but the OTC segment has attracted new entrants since the FDA rule change.
Has InnerScope disclosed any institutional investors?
InnerScope has not publicly named any institutional investors, venture capital firms, or family offices. The company's financial structure and ownership are not disclosed. No fundraising rounds have been reported in public filings or press releases.
Are InnerScope's hearing aids FDA-registered?
OTC hearing aids sold in the US since October 2022 must comply with FDA regulations for the category. InnerScope's products, sold through its website, would fall under these rules. The company has not published specific FDA registration numbers or clinical data for its devices.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: